Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy.
Saved in:
| Title: | Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy. |
|---|---|
| Authors: | Wang H; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Penn Neurodegeneration Genomics Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Chang TS; Movement Disorders Programs, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Dombroski BA; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Penn Neurodegeneration Genomics Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Cheng PL; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Penn Neurodegeneration Genomics Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Patil V; Movement Disorders Programs, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Valiente-Banuet L; Movement Disorders Programs, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Farrell K; Department of Pathology, Department of Artificial Intelligence & Human Health, Nash Family, Department of Neuroscience, Ronald M. Loeb Center for Alzheimer's Disease, Friedman Brain, Institute, Neuropathology Brain Bank & Research CoRE, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Mclean C; Victorian Brain Bank, The Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia., Molina-Porcel L; Alzheimer's Disease and Other Cognitive Disorders Unit. Neurology Service, Hospital Clínic, Fundació Recerca Clínic Barcelona (FRCB). Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.; Neurological Tissue Bank of the Biobanc-Hospital Clínic-IDIBAPS, Barcelona, Spain., Rajput A; Movement Disorders Program, Division of Neurology, University of Saskatchewan, Saskatoon, SK, Canada., De Deyn PP; Laboratory of Neurochemistry and Behavior, Experimental Neurobiology Unit, University of Antwerp, Wilrijk (Antwerp), Belgium.; Department of Neurology, University Medical Center Groningen, NL-9713 AV, Groningen, Netherlands., Le Bastard N; Fujirebio Europe NV, Technologiepark 6, 9052, Ghent, Belgium., Gearing M; Department of Pathology and Laboratory Medicine and Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA., Kaat LD; Netherlands Brain Bank and Erasmus University, Rotterdam, Netherlands., Van Swieten JC; Netherlands Brain Bank and Erasmus University, Rotterdam, Netherlands., Dopper E; Netherlands Brain Bank and Erasmus University, Rotterdam, Netherlands., Ghetti BF; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA., Newell KL; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA., Troakes C; London Neurodegenerative Diseases Brain Bank, King's College London, London, UK., de Yébenes JG; Autonomous University of Madrid, Madrid, Spain., Rábano-Gutierrez A; Fundación CIEN (Centro de Investigación de Enfermedades Neurológicas) - Centro Alzheimer Fundación Reina Sofía, Madrid, Spain., Meller T; Department of Neurology, Philipps-Universität, Marburg, Germany., Oertel WH; Department of Neurology, Philipps-Universität, Marburg, Germany., Respondek G; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany., Stamelou M; Parkinson's Disease and Movement Disorders Department, HYGEIA Hospital, Athens, Greece.; European University of Cyprus, Nicosia, Cyprus., Arzberger T; Department of Psychiatry and Psychotherapy, University Hospital Munich, Ludwig-Maximilians-University Munich, Munich, Germany.; Center for Neuropathology and Prion Research, Ludwig-Maximilians-University Munich, Munich, Germany., Roeber S; German Brain Bank, Neurobiobank Munich, Munich, Germany., Müller U; German Brain Bank, Neurobiobank Munich, Munich, Germany., Hopfner F; Department of Neurology, LMU University Hospital, Ludwig-Maximilians-Universität (LMU) München; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; and Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Pastor P; Unit of Neurodegenerative Diseases, Department of Neurology, University Hospital Germans Trias I Pujol, Badalona, Barcelona, Spain.; Neurosciences, The Germans Trias I Pujol Research Institute (IGTP) Badalona, Badalona, Spain., Brice A; Sorbonne Université, Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, APHP - Hôpital Pitié-Salpêtrière, Paris, France., Durr A; Sorbonne Université, Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, APHP - Hôpital Pitié-Salpêtrière, Paris, France., Le Ber I; Sorbonne Université, Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, APHP - Hôpital Pitié-Salpêtrière, Paris, France., Beach TG; Banner Sun Health Research Institute, Sun City, AZ, USA., Serrano GE; Banner Sun Health Research Institute, Sun City, AZ, USA., Hazrati LN; University McGill, Montreal, QC, Canada., Litvan I; Department of Neuroscience, University of California, San Diego, CA, USA., Rademakers R; VIB Center for Molecular Neurology, University of Antwerp, Antwerp, Belgium.; Department of Neuroscience, Mayo Clinic Jacksonville, Jacksonville, FL, USA., Ross OA; Department of Neuroscience, Mayo Clinic Jacksonville, Jacksonville, FL, USA., Galasko D; Department of Neuroscience, University of California, San Diego, CA, USA., Boxer AL; Memory and Aging Center, University of California, San Francisco, CA, USA., Miller BL; Memory and Aging Center, University of California, San Francisco, CA, USA., Seeley WW; Memory and Aging Center, University of California, San Francisco, CA, USA., Van Deerlin VM; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Lee EB; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Neurodegenerative Disease Research, University of Pennsylvania School of Medicine, Philadelphia, PA, USA., White CL 3rd; University of Texas Southwestern Medical Center, Dallas, TX, USA., Morris H; Departmento of Clinical and Movement Neuroscience, University College of London, London, UK., de Silva R; Reta Lila Weston Institute, UCL Queen Square Institute of Neurology, London, UK., Crary JF; Department of Pathology, Department of Artificial Intelligence & Human Health, Nash Family, Department of Neuroscience, Ronald M. Loeb Center for Alzheimer's Disease, Friedman Brain, Institute, Neuropathology Brain Bank & Research CoRE, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Goate AM; Department of Genetics and Genomic Sciences, New York, NY, USA; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Friedman JS; Friedman Bioventure, Inc., Del Mar, CA, USA., Leung YY; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Penn Neurodegeneration Genomics Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Coppola G; Movement Disorders Programs, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.; Department of Psychiatry, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA., Naj AC; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Penn Neurodegeneration Genomics Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Wang LS; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Penn Neurodegeneration Genomics Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Dalgard C; Department of Anatomy Physiology and Genetics, the American Genome Center, Uniformed Services University of the Health Sciences, Bethesda, MD, USA., Dickson DW; Department of Neuroscience, Mayo Clinic Jacksonville, Jacksonville, FL, USA. Dickson.Dennis@mayo.edu., Höglinger GU; Department of Neurology, LMU University Hospital, Ludwig-Maximilians-Universität (LMU) München; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; and Munich Cluster for Systems Neurology (SyNergy), Munich, Germany. guenter.hoeglinger@med.uni-muenchen.de., Schellenberg GD; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. gerardsc@pennmedicine.upenn.edu.; Penn Neurodegeneration Genomics Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. gerardsc@pennmedicine.upenn.edu., Geschwind DH; Movement Disorders Programs, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. dhg@mednet.ucla.edu.; Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. dhg@mednet.ucla.edu.; Institute of Precision Health, University of California, Los Angeles, Los Angeles, CA, USA. dhg@mednet.ucla.edu., Lee WP; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. wan-ping.lee@pennmedicine.upenn.edu.; Penn Neurodegeneration Genomics Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. wan-ping.lee@pennmedicine.upenn.edu. |
| Corporate Authors: | P. S. P. genetics study group |
| Source: | Molecular neurodegeneration [Mol Neurodegener] 2024 Aug 16; Vol. 19 (1), pp. 61. Date of Electronic Publication: 2024 Aug 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101266600 Publication Model: Electronic Cited Medium: Internet ISSN: 1750-1326 (Electronic) Linking ISSN: 17501326 NLM ISO Abbreviation: Mol Neurodegener Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1750-1326 |
|---|---|
| DOI: | 10.1186/s13024-024-00747-3 |
